- Home
- HITI vs RCEL Comparison
HITI vs RCEL Comparison
Compare HITI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- RCEL
- Stock Information
- Founded
- HITI 2009
- RCEL N/A
- Country
- HITI Canada
- RCEL United States
- Employees
- HITI N/A
- RCEL N/A
- Industry
- HITI
- RCEL Medical/Dental Instruments
- Sector
- HITI
- RCEL Health Care
- Exchange
- HITI Nasdaq
- RCEL Nasdaq
- Market Cap
- HITI 187.8M
- RCEL 161.5M
- IPO Year
- HITI N/A
- RCEL N/A
- Fundamental
- Price
- HITI $2.19
- RCEL $5.19
- Analyst Decision
- HITI Strong Buy
- RCEL Strong Buy
- Analyst Count
- HITI 2
- RCEL 4
- Target Price
- HITI $4.75
- RCEL $16.50
- AVG Volume (30 Days)
- HITI 293.1K
- RCEL 287.8K
- Earning Date
- HITI 06-16-2025
- RCEL 08-07-2025
- Dividend Yield
- HITI N/A
- RCEL N/A
- EPS Growth
- HITI N/A
- RCEL N/A
- EPS
- HITI N/A
- RCEL N/A
- Revenue
- HITI $398,202,371.00
- RCEL $71,661,000.00
- Revenue This Year
- HITI $12.43
- RCEL $57.29
- Revenue Next Year
- HITI $11.39
- RCEL $28.07
- P/E Ratio
- HITI N/A
- RCEL N/A
- Revenue Growth
- HITI 9.22
- RCEL 41.35
- 52 Week Low
- HITI $1.57
- RCEL $5.10
- 52 Week High
- HITI $3.62
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- HITI 39.78
- RCEL 29.07
- Support Level
- HITI $2.10
- RCEL $5.10
- Resistance Level
- HITI $2.35
- RCEL $6.33
- Average True Range (ATR)
- HITI 0.09
- RCEL 0.32
- MACD
- HITI -0.01
- RCEL 0.02
- Stochastic Oscillator
- HITI 32.76
- RCEL 6.10
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.